These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23043158)

  • 1. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.
    Chen Y; Hu Y; Lin M; Jenkins AJ; Keech AC; Mott R; Lyons TJ; Ma JX
    Diabetes; 2013 Jan; 62(1):261-72. PubMed ID: 23043158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.
    Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
    Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q
    Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.
    Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX
    Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.
    Qiu F; Matlock G; Chen Q; Zhou K; Du Y; Wang X; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5065-5075. PubMed ID: 28980001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic Role of
    Chen Q; Qiu F; Zhou K; Matlock HG; Takahashi Y; Rajala RVS; Yang Y; Moran E; Ma JX
    Diabetes; 2017 Jun; 66(6):1671-1682. PubMed ID: 28270521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction.
    Hu Y; Chen Y; Ding L; He X; Takahashi Y; Gao Y; Shen W; Cheng R; Chen Q; Qi X; Boulton ME; Ma JX
    Proc Natl Acad Sci U S A; 2013 Sep; 110(38):15401-6. PubMed ID: 24003152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of PPARα in retinopathy of type 1 diabetes.
    Pearsall EA; Cheng R; Matsuzaki S; Zhou K; Ding L; Ahn B; Kinter M; Humphries KM; Quiambao AB; Farjo RA; Ma JX
    PLoS One; 2019; 14(2):e0208399. PubMed ID: 30716067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective and antioxidant effects of PPARα in the ischemic retina.
    Moran E; Ding L; Wang Z; Cheng R; Chen Q; Moore R; Takahashi Y; Ma JX
    Invest Ophthalmol Vis Sci; 2014 May; 55(7):4568-76. PubMed ID: 24825105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARα regulates mobilization and homing of endothelial progenitor cells through the HIF-1α/SDF-1 pathway.
    Wang Z; Moran E; Ding L; Cheng R; Xu X; Ma JX
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3820-32. PubMed ID: 24845641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct effects of PPARα agonists on retinal inflammation and angiogenesis may explain how fenofibrate lowers risk of severe proliferative diabetic retinopathy.
    Abcouwer SF
    Diabetes; 2013 Jan; 62(1):36-8. PubMed ID: 23258912
    [No Abstract]   [Full Text] [Related]  

  • 12. Salutary effect of fenofibrate on type 1 diabetic retinopathy via inhibiting oxidative stress-mediated Wnt/β-catenin pathway activation.
    Liu Q; Zhang X; Cheng R; Ma JX; Yi J; Li J
    Cell Tissue Res; 2019 May; 376(2):165-177. PubMed ID: 30610453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
    Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
    Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Protective Effect of PPARα in Endothelial Progenitor Cells Through Regulating Metabolism.
    Shao Y; Chen J; Dong LJ; He X; Cheng R; Zhou K; Liu J; Qiu F; Li XR; Ma JX
    Diabetes; 2019 Nov; 68(11):2131-2142. PubMed ID: 31451517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Monocyte Activation by PPARα Through Interaction With the cGAS-STING Pathway.
    Dong L; Cheng R; Ma X; Liang W; Hong Y; Li H; Zhou K; Du Y; Takahashi Y; Zhang X; Li XR; Ma JX
    Diabetes; 2023 Jul; 72(7):958-972. PubMed ID: 37058417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
    Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy.
    Joharapurkar A; Patel V; Kshirsagar S; Patel MS; Savsani H; Jain M
    Eur J Pharmacol; 2021 May; 899():174032. PubMed ID: 33753107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Fenofibrate on the Expression of Inflammatory Mediators in a Diabetic Rat Model.
    Yeh PT; Wang LC; Chang SW; Yang WS; Yang CM; Yang CH
    Curr Eye Res; 2019 Oct; 44(10):1121-1132. PubMed ID: 31109206
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-inflammatory and antioxidant effects of SERPINA3K in the retina.
    Zhang B; Hu Y; Ma JX
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3943-52. PubMed ID: 19324842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARα activation directly upregulates thrombomodulin in the diabetic retina.
    Shiono A; Sasaki H; Sekine R; Abe Y; Matsumura Y; Inagaki T; Tanaka T; Kodama T; Aburatani H; Sakai J; Takagi H
    Sci Rep; 2020 Jul; 10(1):10837. PubMed ID: 32616724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.